Novartis India Limited (NOVARTIND.BO)
Novartis India Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mumbai, MA, IN. The stock last traded at $1586.70, up 2.30% on the session, giving a market capitalisation of $39.18B. Its beta of 0.32 implies it has historically moved less than the broad market.
Novartis India Limited, an affiliate of Novartis AG, operates as a healthcare enterprise primarily within India. The company's diverse portfolio encompasses a range of therapeutic solutions. These include bone and pain management treatments sold under the Voveran brand, an array of transplantation immunology medications such as Simulect, Certican, Sandimmun, Neoral, and Myfortic, and neuroscience products like Tegrital and Exelon. Founded in 1947, its principal operations are based in Mumbai, India.
Novartis India Limited is most often compared with the following Healthcare names: